Literature DB >> 8927501

Recombinant troponin I substitution and calcium responsiveness in skinned cardiac muscle.

J D Strauss1, J E Van Eyk, Z Barth, L Kluwe, R J Wiesner, K Maéda, J C Rüegg.   

Abstract

Using treatment with vanadate solutions, we extracted native cardiac troponin I and troponin C (cTnI and cTnC) from skinned fibers of porcine right ventricles. These proteins were replaced by exogenously supplied TnI and TnC isoforms, thereby restoring Ca2+-dependent regulation. Force then depended on the negative logarithm of Ca2+ concentration (pCa) in a sigmoidal manner, the pCa for 50% force development, pCa50, being about 5.5. For reconstitution we used fast-twitch rabbit skeletal muscle TnI and TnC (sTnI and sTnC), bovine cTnI and cTnC or recombinant sTnIs that were altered by site-directed mutagenesis. Incubation with TnI inhibited isometric tension in TnI-extracted fibers in the absence of Ca2+, but restoration of Ca2+ dependence required incubation with both TnI and TnC. Relaxation at low Ca2+ levels and the steepness of the force/pCa relation depended on the concentration of exogenously supplied TnI in the reconstitution solution (range 20-150 "mu"M), while Ca2+ sensitivity, i.e. the pCa50, was dependent on the isoform, and also on the concentration of TnC in the reconstitution solution. At pH 6.7, skinned fibers reconstituted with optimal concentrations of sTnC and sTnI (120 "mu"M and 150 "mu"M, respectively) were more sensitive to Ca2+ than those reconstituted with cTnC and cTnI (difference in pCa50 approx. 0.2 units). Rabbit sTnI was cloned and expressed in Escherichia coli using a high yield expression plasmid. We introduced point mutations into the TnI inhibitory region comprising the sequence of the minimal common TnC/actin binding site (-G104-K-F-K-R-P-P-L-R-R-V-R115-). The four mutants produced by substitution of T for P110, G for P110, G for L111, and G for K105 were chosen, based on previous work with synthetic peptides showing that single amino acid substitution in this region diminished the capacity of these peptides to inhibit acto-S1 ATPase or contraction of skinned fibers. Therefore, all amino acid residues of the inhibitory region are thought to contribute to biological activity of TnI. However, each of the recombinant TnIs could substitute for endogenous TnI. In combination with exogenous TnC, Ca2+ dependence could be restored when gly110sTnI, thr110sTnI or gly111sTnI was used for reconstitution. The mutant gly105sTnI, on the other hand, reduced the ability of skinned fibers to relax at low Ca2+ concentrations and it caused an increase in Ca2+ sensitivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8927501     DOI: 10.1007/s004240050077

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  38 in total

1.  A synthetic peptide of the N-terminus of actin interacts with myosin.

Authors:  J E Van Eyk; R S Hodges
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

2.  Effect of troponin C on the cooperativity in Ca2+ activation of cardiac muscle.

Authors:  J Gulati; S Scordilis; A Babu
Journal:  FEBS Lett       Date:  1988-08-29       Impact factor: 4.124

3.  Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction.

Authors:  B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  E. coli expression and characterization of a mutant troponin I with the three cysteine residues substituted.

Authors:  L Kluwe; K Maeda; Y Maéda
Journal:  FEBS Lett       Date:  1993-05-24       Impact factor: 4.124

5.  The thin filament of vertebrate skeletal muscle co-operatively activates as a unit.

Authors:  P W Brandt; M S Diamond; F H Schachat
Journal:  J Mol Biol       Date:  1984-12-05       Impact factor: 5.469

6.  Probing the calcium-induced conformational transition of troponin C with site-directed mutants.

Authors:  K Fujimori; M Sorenson; O Herzberg; J Moult; F C Reinach
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

7.  The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated.

Authors:  J Wattanapermpool; X Guo; R J Solaro
Journal:  J Mol Cell Cardiol       Date:  1995-07       Impact factor: 5.000

8.  Structural and regulatory functions of the NH2- and COOH-terminal regions of skeletal muscle troponin I.

Authors:  C S Farah; C A Miyamoto; C H Ramos; A C da Silva; R B Quaggio; K Fujimori; L B Smillie; F C Reinach
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

9.  Contributions of troponin I and troponin C to the acidic pH-induced depression of contractile Ca2+ sensitivity in cardiotrabeculae.

Authors:  X L Ding; A B Akella; J Gulati
Journal:  Biochemistry       Date:  1995-02-21       Impact factor: 3.162

10.  Ion-specific and general ionic effects on contraction of skinned fast-twitch skeletal muscle from the rabbit.

Authors:  M A Andrews; D W Maughan; T M Nosek; R E Godt
Journal:  J Gen Physiol       Date:  1991-12       Impact factor: 4.086

View more
  3 in total

1.  A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.

Authors:  Laura C Preston; Hugh Watkins; Charles S Redwood
Journal:  J Muscle Res Cell Motil       Date:  2006-10-19       Impact factor: 2.698

2.  Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.

Authors:  David Burton; Hassan Abdulrazzak; Adam Knott; Kathryn Elliott; Charles Redwood; Hugh Watkins; Steven Marston; Chris Ashley
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

3.  The troponin I: inhibitory peptide uncouples force generation and the cooperativity of contractile activation in mammalian skeletal muscle.

Authors:  Fred Schachat; Philip W Brandt
Journal:  J Muscle Res Cell Motil       Date:  2013-01-23       Impact factor: 2.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.